ScienceMore in Science →
Engineering Biology Offers a Cheaper Route to Making Lenacapavir
Researchers at the Manchester Institute of Biotechnology say engineering biology could provide a cheaper and more sustainable way to manufacture the HIV drug Lenacapavir.
Key Takeaways
- A Manchester team says engineering biology can improve Lenacapavir production.
- The reported advance combines cost reduction with sustainability goals.
DE
DT Editorial AI··via phys.org